Breast Cancer · LIVING RESEARCH LIBRARY

Ongoing Research for Breast Cancer Using Advanced Alternative Medicine

Explore positive published findings by substance, cancer biology, treatment interaction and quality-of-life outcome.

Every entry includes the original study title, year, concise finding and a direct PubMed link.

Call 1.800.923.7878

Ask About Your Breast Cancer Case

Tell us the diagnosis, stage, biomarkers, current treatment plan and research questions you want to understand. Our Patient Care Team will follow up personally.

Prefer to speak now?
Call 1.800.923.7878

Living research library · positive published findings

Research organized by substance and finding

Browse 33 source-linked studies with the full title, publication year, research focus and a concise finding. Select any linked substance to move directly to its corresponding Sunridge page.

Anti-proliferation effects of Apatinib in combination with Curcumin in breast cancer cells.

2023 · Tumor growth and proliferation

The obtained results showed that all treatments of Apatinib, Curcumin, and Apa-Cur significantly decreased viability and proliferation of the breast cancer cells in a concentration- and time-dependent manner.

Open study on PubMed →

Curcumin inhibits the invasion and metastasis of triple negative breast cancer via Hedgehog/Gli1 signaling pathway.

2022 · Metastasis and invasion

Modern pharmacological studies have found that curcumin has many kinds of pharmacological activities of anti-inflammatory, anti-tumor, anti-angiogenesis, anti-metastasis and anti-multidrug resistance.

Open study on PubMed →

Curcumin Inhibits the Tumorigenesis of Breast Cancer by Blocking Tafazzin/Yes-Associated Protein Axis.

2020 · Metastasis and invasion

Curcumin (20 and 30 μM) inhibited the proliferation, migration and invasion, and promoted the apoptosis of MCF-7 and MDA-MB-231 cells.

Open study on PubMed →

Fabrication of Ginsenoside-Based Nanodrugs for Enhanced Antitumor Efficacy on Triple-Negative Breast Cancer.

2022 · Metastasis and invasion

Ginsenosides can reportedly induce tumor cell death, invasion, and metastasis; however, poor water solubility, low oral absorption rate, and rapid blood clearance limit their clinical application.

Open study on PubMed →

Ginsenoside CK induces apoptosis in triple-negative breast cancer cells by targeting glutamine metabolism.

2022 · Apoptosis and cell death

Ginsenoside CK (CK) can effectively inhibit triple-negative breast cancer (TNBC), the occurrence and development of which are associated with glutamine addiction.

Open study on PubMed →

Ginsenoside Rh2 inhibits breast cancer cell growth via ERβ-TNFα pathway.

2022 · Apoptosis and cell death

Our results showed that ginsenoside Rh2 induced apoptosis and G1/S phase arrest in MCF-7 cells.

Open study on PubMed →

Ginsenoside Rh2 regulates triple-negative breast cancer proliferation and apoptosis via the IL-6/JAK2/STAT3 pathway.

2024 · Apoptosis and cell death

Additionally, ELISA, Western blot, and quantitative real-time PCR were used to further investigate the mechanisms of ginsenoside Rh2-induced apoptosis in TNBC cells.

Open study on PubMed →

Insulin-induced enhancement of antitumoral response to methotrexate in breast cancer patients

2004 · Survival and clinical response

In a randomized study of multidrug-resistant metastatic breast cancer, insulin plus methotrexate produced greater disease control than either treatment used separately.

Open study on PubMed →

Insulin-induced enhancement of MCF-7 breast cancer cell response to 5-fluorouracil and cyclophosphamide

2017 · Treatment response

Insulin sensitized breast-cancer cells to 5-fluorouracil and cyclophosphamide through cell-cycle and drug-transport-associated mechanisms.

Open study on PubMed →

Effects of Melatonin and Doxorubicin on Primary Tumor And Metastasis in Breast Cancer Model.

2022 · Metastasis and invasion

Tumor growth and metastasis were markedly suppressed in melatonin alone and in combination with doxorubicin.

Open study on PubMed →

Melatonin inhibits breast cancer cell invasion through modulating DJ-1/KLF17/ID-1 signaling pathway.

2019 · Metastasis and invasion

Melatonin and taxol clearly decreased cell migration and invasion at low doses, especially those matching the normal physiological concentration at night.

Open study on PubMed →

The evaluation of melatonin and EGF interaction on breast cancer metastasis.

2024 · Metastasis and invasion

The results of this study show that melatonin in the presence of EGF does not show the anti-cancer properties previously described for this substance.

Open study on PubMed →

The Mistletoe and Breast Cancer (MAB) Study: A UK Mixed-Phase, Pilot, Placebo-Controlled, Double-Blind, Randomised Controlled Trial.

2025 · Cancer biology and response

To test the feasibility of a mixed-phase, pilot, placebo-controlled, double-blind trial of mistletoe therapy (MT) with an embedded qualitative study in the UK National Health Service (NHS) setting.

Open study on PubMed →

Effects of sulforaphane on breast cancer based on metabolome and microbiome.

2023 · Metabolism and redox biology

Sulforaphane (SFN) is a promising phytochemical with a wide range of antitumor activities.

Open study on PubMed →

Endocrine-targeting therapies shift the breast microbiome to reduce estrogen receptor-α breast cancer risk.

2025 · Tumor growth and proliferation

In B6.MMTV-PyMT mice, intra-nipple probiotic bacteria injections reduced tumorigenesis, altered metabolic gene expression, and decreased tumor proliferation.

Open study on PubMed →

Gut microbiota and glycochenodeoxycholic role in liver metastasis of breast cancer.

2025 · Metastasis and invasion

In vitro experiments showed that GCDC inhibited breast cancer cell proliferation, migration, and invasion while inducing cell death.

Open study on PubMed →

Intestinal Microbiota Influence Doxorubicin Responsiveness in Triple-Negative Breast Cancer.

2022 · Metastasis and invasion

Taken together, we show that modulating the gut microbiota through antibiotics, HFD-FMT, or by administering LPS influenced TNBC chemotherapy responsiveness, lung metastasis, and intestinal inflammation.

Open study on PubMed →

Natural exosome-like nanovesicles from edible tea flowers suppress metastatic breast cancer via ROS generation and microbiota modulation.

2022 · Metastasis and invasion

Further mice investigations demonstrated that TFENs after intravenous (i.v.) injection or oral administration could accumulate in breast tumors and lung metastatic sites, inhibit the growth and metastasis of breast cancer, and modulate gut microbiota.

Open study on PubMed →

Quercetin inhibits breast cancer cell proliferation and survival by targeting Akt/mTOR/PTEN signaling pathway.

2024 · Tumor growth and proliferation

Therefore, we aimed to examine quercetin impacts on breast cancer cell proliferation and survival and the involvement of PI3K/Akt/mTOR pathway.

Open study on PubMed →

Resveratrol in Cancer Treatment with a Focus on Breast Cancer.

2023 · Metastasis and invasion

Resveratrol can affect numerous signaling pathways in vitro, leading to the induction of cell cycle arrest and apoptosis, suppression of proliferation, reduction of inflammatory responses, and the inhibition of angiogenesis and metastasis.

Open study on PubMed →

Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy.

2017 · Treatment response

Treatment of DOX-resistant MDA-MB-435 cells with silibinin at 200 μM reduced DOX IC50 from 71 to 10 μg/mL and significantly suppressed the key oncogenic pathways including STAT3, AKT, and ERK in these cells.

Open study on PubMed →

Silibinin-induced apoptosis of breast cancer cells involves mitochondrial impairment.

2019 · Apoptosis and cell death

Moreover, treatments with DRP1 inhibitor, mdivi-1, or with DRP1-targetted siRNA efficiently prevent silibinin-induced apoptosis in the breast cancer cells, whereas inhibition of DRP1 phosphorylation with staurosporine increases apoptosis furthermore.

Open study on PubMed →

Bicarbonate increases tumor pH and inhibits spontaneous metastases

2009 · Metastasis and invasion

Sodium bicarbonate increased tumor pH and reduced spontaneous metastases and lymph-node involvement in metastatic breast-cancer models.

Open study on PubMed →

Immunotherapy Enhancement by Targeting Extracellular Tumor pH in Triple-Negative Breast Cancer Mouse Model

2023 · Treatment response

Sodium bicarbonate enhanced anti-PD-L1-associated immunity, tumor-growth inhibition and survival in the reported triple-negative breast-cancer model.

Open study on PubMed →

Investigating mechanisms of alkalinization for reducing primary breast tumor invasion

2013 · Metastasis and invasion

Bicarbonate-treated breast-tumor models had fewer circulating tumor cells, reduced invasion-associated protease activity and slower invasion.

Open study on PubMed →

Cetuximab-conjugated sodium selenite nanoparticles for doxorubicin targeted delivery against MCF-7 breast cancer cells.

2024 · Treatment response

Cytotoxicity studies showed significant effects and high apoptosis in MCF-7 cells for both formulations.Conclusion: The mAb-SSNP-DOX showed promising properties, more effective doxorubicin release and higher cytotoxicity against breast cancer cells compared with SSNP-DOX.

Open study on PubMed →

Sodium Selenite Alleviates Breast Cancer-Related Lymphedema Independent of Antioxidant Defense System.

2019 · Cancer biology and response

Sodium selenite improved diagnostic stages of BCRL along with ECW ratios, although the beneficial effect might not be related to its antioxidant activity.

Open study on PubMed →

Sulforaphane suppresses metastasis of triple-negative breast cancer cells by targeting the RAF/MEK/ERK pathway.

2022 · Metastasis and invasion

Here, we showed that SFN, including its two isomers of R-SFN and S-SFN, significantly inhibited TGF-β1-induced migration and invasion in breast cancer cells.

Open study on PubMed →

Vitamin C sensitizes triple negative breast cancer to PI3K inhibition therapy.

2021 · Treatment response

Treatment with buparlisib at lower doses, along with vitamin C, induced apoptosis and inhibited the growth of TNBC cells in vitro.

Open study on PubMed →

High-dose vitamin D metabolite delivery inhibits breast cancer metastasis.

2022 · Metastasis and invasion

When administered to mice, this nanosystem demonstrates high calcitriol doses in breast tumor cells, significant tumor growth inhibition and antimetastasis capability, as well as good biocompatibility.

Open study on PubMed →

Increased Antiproliferative Activity of Antiestrogens and Neratinib Treatment by Calcitriol in HER2-Positive Breast Cancer Cells.

2025 · Tumor growth and proliferation

The results demonstrated that calcitriol and neratinib, per se, significantly inhibited cell proliferation in a concentration-dependent manner in the HER2-positive cell lines.

Open study on PubMed →

Intestinal vitamin D receptor protects against extraintestinal breast cancer tumorigenesis.

2023 · Immune and inflammatory signaling

Furthermore, treatment with the beneficial bacterial metabolite butyrate or the probiotic Lactobacillus plantarum reduced breast tumors, enhanced tight junctions, inhibited inflammation, increased butyryl-CoA transferase, and decreased levels of breast Streptococcus bacteria in VDRΔIEC mice.

Open study on PubMed →

Vitamin D receptor as a target for breast cancer therapy.

2017 · Cancer biology and response

Using the MTT assay, IC50 concentrations for response to calcitriol varied from 0.12 µM to >20 µM, whereas those for inecalcitol were significantly lower, ranging from 2.5 nM to 63 nM (P = 0.001).

Open study on PubMed →

Scottsdale Clinic

14200 N Northsight Blvd #160
Scottsdale, Arizona 85260

Office Hours

Monday–Friday: 9:00 AM–5:00 PM
Saturday: 9:00 AM–12:00 PM

Visit Sunridge in Scottsdale

FREE INTRODUCTORY CALL

Speak With Our Patient Care Team

Tell us what you are facing. There is no charge to speak with our Patient Care Team, understand how Sunridge works and determine whether a physician consultation may be an appropriate next step.

Call Now: 1-800-923-7878

This introductory call is not a medical consultation and does not establish a physician-patient relationship.

Have a Question or Share Feedback:
It's easy to get in touch with us